
Raymond K. Covington
Examiner (ID: 10694)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1622, 1209, 1107, 1612, 1625, 1203, 1206 |
| Total Applications | 2419 |
| Issued Applications | 1879 |
| Pending Applications | 78 |
| Abandoned Applications | 463 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9570088
[patent_doc_number] => 20140187801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'ASYMETRIC SYNTHESIS OF NORCANTHARIDIN ANALOUGUS BY ALKYNYLATION OF OXABENZONORBORNADIENES AND THEIR ANTICANCER ACTIVITIES'
[patent_app_type] => utility
[patent_app_number] => 13/729479
[patent_app_country] => US
[patent_app_date] => 2012-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2756
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13729479
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/729479 | Asymmetric synthesis of norcantharidin analougus by alkynylation of oxabenzonorbornadienes and their anticancer activities | Dec 27, 2012 | Issued |
Array
(
[id] => 8905079
[patent_doc_number] => 20130172581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'PROCESS FOR THE PRODUCTION OF FURFURAL'
[patent_app_type] => utility
[patent_app_number] => 13/729375
[patent_app_country] => US
[patent_app_date] => 2012-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11028
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13729375
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/729375 | Process for the production of furfural | Dec 27, 2012 | Issued |
Array
(
[id] => 8866889
[patent_doc_number] => 20130150592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'HETEROATOMIC INDENOFLUORENES'
[patent_app_type] => utility
[patent_app_number] => 13/712589
[patent_app_country] => US
[patent_app_date] => 2012-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4534
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13712589
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/712589 | Heteroatomic indenofluorenes | Dec 11, 2012 | Issued |
Array
(
[id] => 10541740
[patent_doc_number] => 09266852
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-23
[patent_title] => 'Daidzein derivative, pharmaceutically acceptable salt and preparation method thereof, and pharmaceutical composition containing same'
[patent_app_type] => utility
[patent_app_number] => 14/362890
[patent_app_country] => US
[patent_app_date] => 2012-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5530
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14362890
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/362890 | Daidzein derivative, pharmaceutically acceptable salt and preparation method thereof, and pharmaceutical composition containing same | Nov 27, 2012 | Issued |
Array
(
[id] => 10954660
[patent_doc_number] => 20140357682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'ANDROGEN RECEPTOR LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 14/360081
[patent_app_country] => US
[patent_app_date] => 2012-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13835
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14360081
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/360081 | Androgen receptor ligands | Nov 22, 2012 | Issued |
Array
(
[id] => 10876534
[patent_doc_number] => 08901322
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-02
[patent_title] => 'Crystalline forms of cabazitaxel and process for preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 13/683062
[patent_app_country] => US
[patent_app_date] => 2012-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 7529
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13683062
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/683062 | Crystalline forms of cabazitaxel and process for preparation thereof | Nov 20, 2012 | Issued |
Array
(
[id] => 9983863
[patent_doc_number] => 09029579
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-12
[patent_title] => 'Method of synthesizing low color furan diesters'
[patent_app_type] => utility
[patent_app_number] => 13/672022
[patent_app_country] => US
[patent_app_date] => 2012-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3586
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13672022
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/672022 | Method of synthesizing low color furan diesters | Nov 7, 2012 | Issued |
Array
(
[id] => 9464196
[patent_doc_number] => 20140128623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'Method of Synthesizing Low Color Furan Diesters'
[patent_app_type] => utility
[patent_app_number] => 13/671941
[patent_app_country] => US
[patent_app_date] => 2012-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4748
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13671941
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/671941 | Method of synthesizing low color furan diesters | Nov 7, 2012 | Issued |
Array
(
[id] => 9772670
[patent_doc_number] => 20140296333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'COMPOSITION OF THE TREATMENT OF VASCULAR DISEASES OR KCa3.1 CHANNEL-MEDIATED DISEASES COMPRISING MODAFINIL OR DERIVATIVES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/354332
[patent_app_country] => US
[patent_app_date] => 2012-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10933
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354332
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/354332 | Composition of the treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or derivatives thereof | Oct 23, 2012 | Issued |
Array
(
[id] => 10906405
[patent_doc_number] => 20140309418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'Gambogenic Acid Derivatives, Preparation Method and Application Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/354839
[patent_app_country] => US
[patent_app_date] => 2012-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10453
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354839
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/354839 | Gambogenic acid derivatives, preparation method and application thereof | Sep 27, 2012 | Issued |
Array
(
[id] => 10499592
[patent_doc_number] => 09227986
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-05
[patent_title] => 'Diarylethene compounds and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/348344
[patent_app_country] => US
[patent_app_date] => 2012-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 40695
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348344
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/348344 | Diarylethene compounds and uses thereof | Sep 27, 2012 | Issued |
Array
(
[id] => 8745458
[patent_doc_number] => 20130085175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-04
[patent_title] => 'PROCESS FOR THE PREPARATION OF SULFAMIDE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/630142
[patent_app_country] => US
[patent_app_date] => 2012-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13840
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13630142
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/630142 | Process for the preparation of sulfamide derivatives | Sep 27, 2012 | Issued |
Array
(
[id] => 9503806
[patent_doc_number] => 08742124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-03
[patent_title] => 'Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/628958
[patent_app_country] => US
[patent_app_date] => 2012-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29253
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13628958
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/628958 | Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors | Sep 26, 2012 | Issued |
Array
(
[id] => 8617356
[patent_doc_number] => 20130022668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-24
[patent_title] => 'Biologically Active Taxane Analogs And Methods Of Treatment By Oral Administration'
[patent_app_type] => utility
[patent_app_number] => 13/620852
[patent_app_country] => US
[patent_app_date] => 2012-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21087
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13620852
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/620852 | Biologically active taxane analogs and methods of treatment by oral administration | Sep 14, 2012 | Issued |
Array
(
[id] => 8721290
[patent_doc_number] => 20130072506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => '6,8-DISUBSTITUTED PURINE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/611491
[patent_app_country] => US
[patent_app_date] => 2012-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 29241
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13611491
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/611491 | 6,8-DISUBSTITUTED PURINE COMPOSITIONS | Sep 11, 2012 | Abandoned |
Array
(
[id] => 8815405
[patent_doc_number] => 20130116450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'METHOD FOR ENANTIOSELECTIVE HYDROGENATION OF CHROMENES'
[patent_app_type] => utility
[patent_app_number] => 13/608330
[patent_app_country] => US
[patent_app_date] => 2012-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11288
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13608330
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/608330 | Method for enantioselective hydrogenation of chromenes | Sep 9, 2012 | Issued |
Array
(
[id] => 9518889
[patent_doc_number] => 20140155381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'COMPOUNDS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/235512
[patent_app_country] => US
[patent_app_date] => 2012-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38818
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14235512
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/235512 | COMPOUNDS AND METHODS | Jul 26, 2012 | Abandoned |
Array
(
[id] => 8482920
[patent_doc_number] => 20120282327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'PHOSPHATE-CONTAINING NANOPARTICLE DELIVERY VEHICLE'
[patent_app_type] => utility
[patent_app_number] => 13/548856
[patent_app_country] => US
[patent_app_date] => 2012-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3141
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13548856
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/548856 | Phosphate-containing nanoparticle delivery vehicle | Jul 12, 2012 | Issued |
Array
(
[id] => 8490305
[patent_doc_number] => 20120289712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'PHOSPHATE-CONTAINING NANOPARTICLE DELIVERY VEHICLE'
[patent_app_type] => utility
[patent_app_number] => 13/548972
[patent_app_country] => US
[patent_app_date] => 2012-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3014
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13548972
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/548972 | Phosphate-containing nanoparticle delivery vehicle | Jul 12, 2012 | Issued |
Array
(
[id] => 8607413
[patent_doc_number] => 20130012726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'PROCESS TO EXTRACT QUASSINOIDS'
[patent_app_type] => utility
[patent_app_number] => 13/545720
[patent_app_country] => US
[patent_app_date] => 2012-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7259
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13545720
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/545720 | Process to extract quassinoids | Jul 9, 2012 | Issued |